Cargando…
Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway
Syndecan-4 is a member of the polysaccharide syndecan family and plays a vital role in intervertebral disc development. Several studies have demonstrated the positive relationship between syndecan-4 expression and intervertebral disc degeneration. However, the detailed molecular mechanism by which s...
Autores principales: | Ge, Jun, Cheng, Xiaoqiang, Yuan, Chenxi, Qian, Jiale, Wu, Chunshen, Cao, Cheng, Yang, Huilin, Zhou, Feng, Zou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019137/ https://www.ncbi.nlm.nih.gov/pubmed/32071547 http://dx.doi.org/10.7150/ijbs.40189 |
Ejemplares similares
-
TGF-βl Suppresses Inflammation in Cell Therapy for Intervertebral Disc Degeneration
por: Yang, Huilin, et al.
Publicado: (2015) -
The role of TGF‐β1/Smad2/3 pathway in platelet‐rich plasma in retarding intervertebral disc degeneration
por: Yang, Huilin, et al.
Publicado: (2016) -
Calcitonin inhibits intervertebral disc degeneration by regulating protein kinase C
por: Ge, Jun, et al.
Publicado: (2020) -
The protein tyrosine kinase inhibitor, Genistein, delays intervertebral disc degeneration in rats by inhibiting the p38 pathway-mediated inflammatory response
por: Ge, Jun, et al.
Publicado: (2020) -
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
por: Wang, Yidian, et al.
Publicado: (2023)